- ホーム
- > 洋書
- > 英文書
- > Science / Mathematics
Full Description
Nanostructured Drug Delivery Systems in Infectious Disease Treatment explores a broad range of promising approaches for the treatment of infectious diseases using the latest advancements in nanomedical technologies. The book opens with an introduction about infectious diseases and global burdens. There is also specific discussion and assessment of the global impact of viruses with an emphasis on COVID-19, Zika, and Ebola. Subsequent chapters provide detailed information about various novel nanotherapeutic strategies used for delivering drugs for the treatment of various types of viral, bacterial, and fungal disorders. This will be a valuable resource for graduates, researchers, industry professionals, and anyone working to tackle the challenges of delivering drugs in a more targeted and efficient manner for the treatment of infectious diseases.
Contents
1. Introduction to infectious diseases and its global burden
2. Impact assessment of virus globally: Special emphasis on COVID-19, Zika and Ebola virus
3. Nano combinatorial therapies for infectious disorders
4. Stimuli responsive nanotechnological advancements in infectious disorders
5. Application of nanotechnology-based therapy against malaria
6. Therapeutic potential of nano assisted delivery in tuberculosis and its management
7. Exploration of advanced therapeutics for lymphatic and cutaneous leishmania
8. Nanotechnological driven chemotherapy for treatment of fungal infections
9. Nanoantibiotics driven approaches as advanced therapy for bacterial infections and chemotherapeutic resistance
10. Role of biotechnology as theranostic tool in infectious diseases
11. Nanovesicles as advanced tool against infectious diseases
12. Role of nanotechnology derived natural product as potential therapeutics against infectious diseases
13. Nanovaccines as futuristic tool to eradicate infectious diseases
14. Nanotechnology and resistance against biofilm
15. Nanotherapeutics in counteracting brain infection
16. Nanomedicine in infectious disorders: Challenges and regulatory concerns
